Neogen Corporation (NEOG) Financial Statements (2024 and earlier)

Company Profile

Business Address 620 LESHER PLACE
LANSING, MI 48912
State of Incorp. MI
Fiscal Year End May 31
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

8/31/2023
Q1
5/31/2023
Q4
2/28/2023
Q3
11/30/2022
Q2
8/31/2022
Q1
5/31/2022
Q4
2/28/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments245,569183,214276,338347,711381,051378,439
Cash and cash equivalents163,24067,134100,000107,09844,47342,879
Short-term investments82,329116,080176,338240,613336,578335,560
Receivables153,253146,393142,71193,11299,67492,978
Inventory, net of allowances, customer advances and progress billings133,812143,863136,069129,039122,313113,395
Inventory133,812143,863136,069129,039122,313113,395
Other undisclosed current assets53,29781,90188,21538,04523,76024,821
Total current assets:585,931555,371643,333607,907626,798609,633
Noncurrent Assets
Operating lease, right-of-use asset11,9335,0623,7072,8343,1842,762
Property, plant and equipment198,749164,888148,170121,021110,584104,699
Intangible assets, net (including goodwill)3,742,5993,769,5993,764,127243,488250,207262,093
Goodwill2,137,4962,135,1182,122,397140,067142,704150,029
Intangible assets, net (excluding goodwill)1,605,1031,634,4811,641,730103,421107,503112,064
Other noncurrent assets15,22013,8443,9052,1552,1562,018
Total noncurrent assets:3,968,5013,953,3933,919,909369,498366,131371,572
TOTAL ASSETS:4,554,4324,508,7644,563,242977,405992,929981,205
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities140,856100,390147,47573,75672,38465,710
Taxes payable3,9212,126
Employee-related liabilities8,29511,1239,655
Accounts payable76,66960,49479,25127,00234,61423,548
Accrued liabilities64,18739,89668,22434,53824,52132,507
Deferred revenue4,6166,7655,0835,4645,460 
Other undisclosed current liabilities   (12,216)  
Total current liabilities:145,472107,155152,55867,00477,84465,710
Noncurrent Liabilities
Long-term debt and lease obligation885,439884,701923,962   
Long-term debt, excluding current maturities885,439884,701923,962   
Liabilities, other than long-term debt389,304391,353380,45926,60327,71139,951
Deferred income tax liabilities353,427362,630364,25215,94917,01121,196
Other liabilities35,87728,72316,20710,65410,70018,755
Total noncurrent liabilities:1,274,7431,276,0541,304,42126,60327,71139,951
Total liabilities:1,420,2151,383,2091,456,97993,607105,555105,661
Equity
Equity, attributable to parent3,134,2173,125,5553,106,263883,798887,374875,544
Common stock34,59934,59534,58417,25417,24817,251
Additional paid in capital2,567,8282,564,7132,560,898312,750309,984307,780
Accumulated other comprehensive loss(33,251)(33,222)(40,498)(39,326)(27,769)(22,439)
Retained earnings565,041559,469551,279593,120587,911572,952
Total equity:3,134,2173,125,5553,106,263883,798887,374875,544
TOTAL LIABILITIES AND EQUITY:4,554,4324,508,7644,563,242977,405992,929981,205

Income Statement (P&L) ($ in thousands)

8/31/2023
Q1
5/31/2023
Q4
2/28/2023
Q3
11/30/2022
Q2
8/31/2022
Q1
5/31/2022
Q4
2/28/2022
Q3
Revenues241,810218,255230,033132,349140,093128,244
Cost of revenue
(Cost of Goods and Services Sold)
(118,628)(110,291)(117,494)(70,079)(75,094)(70,832)
Gross profit:123,182107,964112,53962,27064,99957,412
Operating expenses(99,757)(92,280)(120,195)(56,208)(46,972)(51,035)
Operating income (loss):23,42515,684(7,656)6,06218,0276,377
Nonoperating income (expense)(15,775)(17,944)(26,435)597882266
Other nonoperating income (expense)1,176(1,124)(6,443)(372)356(48)
Interest and debt expense(9,854)(9,100)(11,000)   
Income (loss) from continuing operations before equity method investments, income taxes:(2,204)(11,360)(45,091)6,65918,9096,643
Other undisclosed income from continuing operations before income taxes9,8549,10011,000   
Income (loss) from continuing operations before income taxes:7,650(2,260)(34,091)6,65918,9096,643
Income tax expense (benefit)(2,078)10,450(7,750)(1,450)(3,950)(1,200)
Income (loss) from continuing operations:5,5728,190(41,841)5,20914,9595,443
Income before gain (loss) on sale of properties:5,20914,9595,443
Net income (loss) available to common stockholders, diluted:5,5728,190(41,841)5,20914,9595,443

Comprehensive Income ($ in thousands)

8/31/2023
Q1
5/31/2023
Q4
2/28/2023
Q3
11/30/2022
Q2
8/31/2022
Q1
5/31/2022
Q4
2/28/2022
Q3
Net income (loss):5,5728,190(41,841)5,20914,9595,443
Other comprehensive income (loss) 7,276(1,172)(11,557) 1,796
Other undisclosed comprehensive loss (29)   (5,330) 
Comprehensive income (loss), net of tax, attributable to parent:5,54315,466(43,013)(6,348)9,6297,239

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: